Gulf Coast Biologics was founded by its President and CEO, Patrick Pennie with a vision of a venue where physicians can be exposed to substantive clinical therapeutics backed by sound evidenced based clinical science. Through a multidisciplinary approach, the aim was to accelerate the development and adoption of regenerative medicine therapies to improve patient outcomes and revolutionize the way we approach disease management. The Gulf Coast Biologics Training Center provides a platform for thought leaders to discuss the latest scientific advancements, explore new treatment modalities, and drive progress towards personalized regenerative medicine.

GCB is committed to fostering a collaborative and inclusive community that values diversity, transparency, and integrity. By promoting scientific rigor, ethical principles, and patient-centricity, we seek to transform the regenerative medicine landscape and make a lasting impact on the overall care of our patients.